Close Asset Management
BNTX icon

Close Asset Management’s BioNTech BNTX Stock Holding History

Close Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6K Hold
61
– – ﹤0.01% 223
2026
Q2 		$6K Hold
61
– – ﹤0.01% 241
2026
Q1 		$5K Hold
61
– – ﹤0.01% 243
2025
Q4 		$6K Hold
61
– – ﹤0.01% 238
2025
Q3 		$6K Buy
+61
New +$6.52K ﹤0.01% 241

Other funds holding BNTX

Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Slow Capital
Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

Close Asset Management's BNTX Position: Q3 2026 in Review

Close Asset Management held its BioNTech (BNTX) position steady in Q3 2026 at 61 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #223.

Close Asset Management first reported a position in BNTX in Q3 2025 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Close Asset Management held 61 shares of BioNTech worth $6K as of Q3 2026.
  • Close Asset Management left its BioNTech share count unchanged in Q3 2026.
  • BioNTech made up ﹤0.01% of Close Asset Management's portfolio in Q3 2026, its #223 holding.
  • Close Asset Management first reported a position in BioNTech in Q3 2025 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Close Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.